Recently, it was reported that RGI-2001, a CD1-binding synthetic derivative of alpha-galactosylceramide, activates and expands iNKT cells (166)

Recently, it was reported that RGI-2001, a CD1-binding synthetic derivative of alpha-galactosylceramide, activates and expands iNKT cells (166). cytokine receptors, such as IL-2 and CD25…